Maravai LifeSciences Holdings, Inc.
MRVI
$2.06
$0.052.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.25% | -43.69% | -0.25% | -0.07% | -10.60% |
| Total Receivables | -27.92% | -29.59% | -41.32% | -20.24% | -30.52% |
| Inventory | -0.15% | -2.56% | 2.58% | 3.99% | -9.07% |
| Prepaid Expenses | -22.92% | -9.96% | -5.49% | -24.21% | -34.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -43.66% | -38.69% | -3.11% | -1.99% | -12.75% |
|
|
|||||
| Total Current Assets | -43.66% | -38.69% | -3.11% | -1.99% | -12.75% |
| Net Property, Plant & Equipment | 2.97% | -2.52% | -23.97% | -19.90% | 4.37% |
| Long-term Investments | -50.96% | -50.96% | -47.31% | -0.13% | -0.17% |
| Goodwill | -50.96% | -50.96% | -47.31% | -0.13% | -0.17% |
| Total Other Intangibles | -6.79% | -11.78% | -11.41% | -11.71% | -11.37% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -23.21% | -22.31% | -92.22% | -91.90% | -90.82% |
| Total Assets | -33.56% | -32.22% | -43.63% | -36.07% | -37.61% |
|
|
|||||
| Total Accounts Payable | 15.79% | 11.45% | 0.74% | 88.28% | 71.95% |
| Total Accrued Expenses | 15.68% | -3.53% | -45.09% | -39.40% | -39.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 29.58% | 6.69% | 2.56% | 2.71% | 4.77% |
| Total Finance Division Other Current Liabilities | -30.12% | -90.57% | 98.52% | 37.89% | -78.51% |
| Total Other Current Liabilities | -30.12% | -90.57% | 98.52% | 37.89% | -78.51% |
| Total Current Liabilities | 7.01% | -34.87% | -19.18% | -8.50% | -52.74% |
|
|
|||||
| Total Current Liabilities | 7.01% | -34.87% | -19.18% | -8.50% | -52.74% |
| Long-Term Debt | -44.10% | -44.00% | -0.62% | -0.63% | -0.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.05% | -8.71% | 1.91% | 1.00% | 25.08% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -12.05% | -7.50% | -99.72% | -99.90% | -99.63% |
| Total Liabilities | -35.63% | -38.21% | -51.64% | -50.89% | -52.84% |
|
|
|||||
| Common Stock & APIC | 38.21% | 40.75% | 39.58% | 39.58% | 17.28% |
| Retained Earnings | -59.46% | -50.69% | -57.36% | -33.17% | -32.38% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -26.80% | -21.95% | -33.54% | -16.07% | -21.26% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.80% | -21.95% | -33.54% | -16.07% | -21.26% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -37.38% | -32.49% | -28.15% | -9.97% | -3.27% |
| Total Equity | -31.79% | -26.92% | -31.29% | -13.50% | -13.68% |
|
|
|||||